1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60FBD7304FB3F324700258B1D00444340
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-global-medical-affairs-resourcing-benchmark-for-med-communications-content-development-functions?opendocument
18
19opendocument
2044.200.140.218
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Global Medical Affairs Resourcing Benchmark for Med Communications & Content Development Functions

ID: 5805


Features:

11 Info Graphics

13 Data Graphics

340+ Metrics

6 Narratives


Pages/Slides: 31


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Global Medical Affairs Resourcing Benchmark for Med Communications & Content Development Functions”

STUDY OVERVIEW

The Med Communications & Content Development function plays a pivotal role in disseminating vital information while navigating intricate regulatory frameworks and cost pressures. Effective resource allocation within this function is paramount, facilitating seamless communication and stakeholder engagement while maximizing operational efficiency.

Finding the optimal balance between insourcing and outsourcing decisions is vital for enhancing core competencies, minimizing costs, and amplifying support across therapeutic domains.

Best Practices, LLC conducted this benchmarking research to delve into the intricacies of resource allocation within Med Communications & Content Development functions. The research investigates productivity metrics, outsourcing benchmarks, expenditure patterns, and staffing dynamics across mid-sized and large biopharma organizations. Equipped with these insights, leadership in Medical Communications & Content Development gains strategic acumen to navigate complexities adeptly, boost productivity, and foster sustainable growth.

KEY TOPICS

  • Outsourcing Trends in Medical Communications / Content Development
  • Scope of Support in Medical Communications / Content Development
  • Productivity and Outsourced Capabilities in Medical Communications / Content Development
  • Staffing Dynamics in Medical Communications / Content Development
  • Benefits of Hybrid Resourcing in Medical Communications / Content Development

KEY METRICS

  • Publications / Content Development scope of support
  • Total spend analysis of Publications / Content Development teams
  • Annual volume of Pubs / Content Development execution across benchmark organizations
  • Capabilities outsourced in Publications / Content Development
  • Outsourcing vs. productivity matrix for various Medical Publications / Content Development activities
  • Number of FTEs (full-time equivalent employees) and CWs (contract workers) dedicated to each role
  • Staffing levels per brand
  • Factors driving outsourcing and insourcing in medical writing

SAMPLE KEY FINDINGS

  • Outsourcing Levels: High levels of outsourcing across all Pubs and Content Development activities are the norm for large and mid-sized biopharma alike.

METHODOLOGY

This study provides tailored benchmarks and insights focused on the Medical Communications / Content Development function. The data from this research is drawn by engaging 22 Medical leaders from 20 leading mid-cap and large biopharma organizations, with expertise encompassing HEOR, Medical Publications & Strategy. Medical Communications / Content Development insights are meticulously distilled to ensure relevance and applicability within the scope of this study.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Consumer Products; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Acadia Pharmaceuticals; Agenus; Alexion Pharmaceuticals; Astellas; Dompé; Fidia Pharma USA Inc.; Gilead Sciences; Novartis; Novo Nordisk; Organon; Pfizer; Pixacore; Protagonist Therapeutics; Regeneron; Sanofi; Sobi; Teva Pharmaceuticals; United Therapeutics; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.